Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27108,107,1.55 [1.15-2.09],0.0039377978775831
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27677,147,1.09 [0.85-1.40],0.5115409970101814
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27430,992,1.28 [1.16-1.41],4.971544211182998e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Candidiasis,27712,302,1.57 [1.32-1.87],2.842279465778294e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26930,2743,1.20 [1.14-1.28],5.54608693476859e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27171,2064,1.24 [1.15-1.32],1.1206565945358282e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27500,993,1.17 [1.06-1.29],0.0014585147879739
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27623,45,1.36 [0.86-2.13],0.1845583199672943
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26454,638,1.47 [1.30-1.65],5.100491129934192e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25578,617,1.54 [1.37-1.74],2.077361008816593e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25816,170,2.01 [1.62-2.50],3.06108589138926e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20654,1200,1.29 [1.18-1.42],1.7408960282068183e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25573,279,1.30 [1.08-1.56],0.0062085373230744
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27664,1157,1.17 [1.07-1.28],0.0007351679052345
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Mycoses,27771,361,1.56 [1.33-1.83],3.3502115584860075e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27040,602,1.38 [1.22-1.56],3.3987111747857426e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27708,707,1.41 [1.26-1.59],3.339333556413685e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26656,149,1.06 [0.83-1.36],0.6286348420034369
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27813,31,1.19 [0.68-2.06],0.5421511239165409
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27619,618,1.46 [1.29-1.64],1.8936202652100528e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27650,72,1.16 [0.81-1.66],0.4197307333404505
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27719,172,1.21 [0.96-1.53],0.1045962207118186
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27703,156,1.16 [0.91-1.48],0.2457653986005006
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26763,325,1.30 [1.10-1.54],0.0025725943810253
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26682,244,1.12 [0.92-1.36],0.2507955539113255
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26585,78,1.22 [0.86-1.73],0.2657395175814357
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27787,53,1.94 [1.33-2.82],0.0005658784277987
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27751,131,0.92 [0.71-1.19],0.5311864373083544
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Viral warts,27664,44,0.86 [0.56-1.33],0.4995378804181526
SLAMF1,Signaling lymphocytic activation molecule,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27671,51,1.00 [0.66-1.52],0.9960793038952992
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm,27528,316,0.96 [0.81-1.14],0.6446041045228093
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27723,76,1.13 [0.80-1.61],0.4883737301506069
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27705,79,0.70 [0.52-0.94],0.0197969811621187
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12421,43,0.88 [0.56-1.40],0.5874361916887471
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27619,1187,0.97 [0.89-1.06],0.4569919970462468
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of meninges,27801,50,0.90 [0.59-1.36],0.6160980642738452
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27777,52,1.78 [1.21-2.62],0.0033488082589384
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27792,91,1.00 [0.73-1.37],0.9916326346138404
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm of ovary,15331,97,0.98 [0.72-1.32],0.8808405738176693
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27806,279,0.99 [0.83-1.19],0.9216972567197614
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Caecum,27803,210,1.08 [0.88-1.33],0.4655234894163855
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27743,58,0.87 [0.59-1.27],0.465329524288132
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Descending colon,27805,177,1.03 [0.82-1.29],0.8263395493178297
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Rectum,27768,294,0.98 [0.83-1.17],0.8484299237849486
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27741,542,0.99 [0.87-1.12],0.843907072195432
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27807,314,0.90 [0.76-1.07],0.2258394142460516
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Carcinoma in situ of breast,13187,89,0.85 [0.62-1.16],0.3085334606181174
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13235,101,0.79 [0.60-1.05],0.1077551997076172
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24040,30,1.36 [0.77-2.38],0.2853001989701548
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24049,39,1.10 [0.67-1.80],0.7005192444593185
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27770,111,1.04 [0.78-1.39],0.7861005173251678
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Haemangioma, any site",27770,109,1.04 [0.78-1.38],0.8133284606127625
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Leiomyoma of uterus,14692,416,0.87 [0.75-1.00],0.0533986082026443
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lung cancer and mesothelioma,20650,177,1.07 [0.85-1.35],0.5570570991935136
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Lymphoid leukaemia,24039,29,1.16 [0.65-2.06],0.6099629392935164
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24158,148,1.03 [0.80-1.32],0.8386244491241626
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24096,86,0.88 [0.64-1.22],0.4475758452732513
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13286,80,1.25 [0.88-1.76],0.2085997040708418
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24062,52,2.34 [1.65-3.33],2.1555802759437627e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24075,65,1.06 [0.72-1.54],0.7751300230685743
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24081,71,1.26 [0.87-1.82],0.2185350841398374
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13260,54,0.79 [0.54-1.15],0.220764259325387
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24067,57,1.13 [0.75-1.71],0.5467430048959211
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11217,413,0.94 [0.81-1.10],0.4539976306403114
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24101,91,1.05 [0.76-1.45],0.7574264639986099
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24066,56,0.86 [0.58-1.28],0.4587928424641097
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24074,64,1.19 [0.81-1.74],0.3871965492407277
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi,27568,214,1.01 [0.82-1.25],0.8979094864251336
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanocytic naevi of trunk,27760,95,1.13 [0.82-1.54],0.4548741425055427
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Melanoma in situ,24024,50,1.13 [0.73-1.75],0.5716402486228063
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24070,60,1.27 [0.85-1.90],0.2379871054691778
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24128,118,1.20 [0.90-1.59],0.2199425354631456
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24130,120,0.90 [0.68-1.19],0.4665196251598426
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24078,68,1.13 [0.77-1.64],0.5358509843111308
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,Other benign neoplasms of skin,27628,141,1.22 [0.95-1.58],0.1241388819996558
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24656,646,1.04 [0.93-1.18],0.4831745434268165
SLAMF1,Signaling lymphocytic activation molecule,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24688,678,1.06 [0.95-1.20],0.3002789759464853
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27541,289,1.55 [1.30-1.85],9.382519292935753e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26398,57,2.14 [1.51-3.04],2.208003774393813e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27322,70,1.64 [1.16-2.32],0.0055705555407091
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27012,2222,1.24 [1.16-1.33],6.434328777503e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26622,25,1.44 [0.78-2.65],0.2406856563323445
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27464,37,1.06 [0.64-1.76],0.8117130242962038
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27368,1027,1.22 [1.11-1.34],4.965343685607113e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27368,1027,1.22 [1.11-1.34],4.965343685607113e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26399,58,2.14 [1.54-2.98],5.262326080570265e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27527,930,1.20 [1.08-1.33],0.000396017681345
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27533,106,1.33 [0.99-1.79],0.0576355069230976
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27305,53,1.67 [1.09-2.54],0.0172378925170391
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27294,42,1.70 [1.09-2.67],0.0201383793785379
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27622,195,1.56 [1.26-1.93],4.55409831786377e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27734,67,1.65 [1.16-2.35],0.0053853657274118
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27590,163,1.66 [1.32-2.08],1.3270869348540848e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26673,76,0.89 [0.64-1.25],0.5126519846648592
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23903,212,1.63 [1.32-2.01],4.688437709407722e-06
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25865,126,1.07 [0.82-1.41],0.6082882416768899
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25877,138,1.55 [1.25-1.92],5.93090208105065e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,23730,39,1.63 [1.00-2.66],0.0508305651861456
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25827,71,1.35 [0.94-1.94],0.1073211303706139
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25475,155,1.26 [0.98-1.62],0.0686795096574314
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27665,166,1.61 [1.28-2.03],6.18202332473157e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27545,46,1.41 [0.90-2.22],0.1324918164629261
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27536,37,1.15 [0.69-1.90],0.5883031396599112
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27398,1642,1.07 [0.99-1.15],0.0759030156644028
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24892,1591,1.09 [1.01-1.18],0.0205223965488347
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",23731,40,1.49 [0.91-2.42],0.1121984993280279
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26112,58,1.84 [1.25-2.71],0.0020542200080184
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23880,189,1.58 [1.26-1.98],5.9985801503529103e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23755,64,1.41 [0.96-2.06],0.0813757463612732
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26090,2399,1.04 [0.98-1.11],0.1913150038589048
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,23815,124,1.44 [1.09-1.90],0.0113290410924658
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24084,393,1.53 [1.31-1.79],7.957333332906405e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27712,274,1.15 [0.96-1.39],0.1297718641268159
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27549,111,1.05 [0.79-1.39],0.7565405579837218
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,23790,99,1.72 [1.27-2.34],0.0004930944508938
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",23731,40,1.29 [0.79-2.11],0.3150754807389104
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27382,1328,1.15 [1.06-1.25],0.0009982700674463
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,23820,129,1.81 [1.39-2.36],1.1591395384462383e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,23856,165,1.46 [1.14-1.85],0.0023257115729783
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24086,395,1.12 [0.96-1.31],0.1603194411052936
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,23751,60,1.20 [0.81-1.80],0.3648896968443488
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27542,104,1.04 [0.77-1.40],0.7846100071932826
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,23994,303,1.46 [1.22-1.75],2.866698343068664e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,23991,300,1.34 [1.12-1.59],0.0014337605038148
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25381,61,1.24 [0.84-1.84],0.2813327546729567
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27120,3429,1.12 [1.06-1.18],2.058417423994768e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26092,38,0.94 [0.58-1.51],0.785418553283693
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26114,60,0.94 [0.64-1.38],0.7396984900606763
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27632,1947,1.08 [1.01-1.16],0.0282828332461324
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27637,1945,1.08 [1.01-1.16],0.0273744457926782
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26093,39,0.94 [0.59-1.52],0.809374147740365
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27488,1254,1.11 [1.02-1.21],0.0204885416558313
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24592,901,1.35 [1.22-1.50],7.927097075520553e-09
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27803,136,1.56 [1.21-2.01],0.0006361090991547
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27532,33,1.39 [0.81-2.38],0.2270499877705948
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26322,88,1.03 [0.74-1.42],0.8720196756744091
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26352,118,0.90 [0.69-1.17],0.4260858791177084
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23826,135,1.38 [1.05-1.80],0.0189648726582893
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26013,123,1.71 [1.31-2.24],8.071389787487186e-05
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1710,70,1.42 [1.02-1.97],0.037861823835792
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1817,191,1.23 [0.98-1.53],0.0714917766003493
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25930,40,1.70 [1.03-2.80],0.0363895697228957
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1676,36,1.52 [0.97-2.38],0.0683500666900415
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27383,1493,1.42 [1.31-1.54],3.565384477100949e-18
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27571,72,1.43 [1.00-2.04],0.0518975792712317
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25598,278,1.10 [0.91-1.32],0.3223831256517494
SLAMF1,Signaling lymphocytic activation molecule,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24105,414,1.37 [1.18-1.59],4.847601654200212e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27729,177,1.15 [0.91-1.45],0.2392455257266321
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27077,57,1.90 [1.29-2.80],0.0011551191031091
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Angina pectoris,26534,796,1.17 [1.05-1.31],0.0037566643473737
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27125,105,1.52 [1.13-2.05],0.0054644135938765
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27051,31,1.28 [0.73-2.25],0.3876908892982605
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27126,106,1.13 [0.84-1.52],0.4384401038838167
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19866,939,1.36 [1.23-1.50],3.762064118615716e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,AV-block,25330,186,0.98 [0.78-1.22],0.8373740356701898
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27779,257,0.95 [0.79-1.15],0.6108260227139015
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiac arrest,19041,114,1.99 [1.54-2.58],1.7667019126277594e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25278,134,1.44 [1.10-1.87],0.0069926602615367
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25225,81,1.76 [1.29-2.41],0.0004293834736111
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27815,21,0.90 [0.47-1.73],0.7619235999525811
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Conduction disorders,25681,537,1.18 [1.03-1.35],0.0152658927517773
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27088,1360,1.19 [1.09-1.29],4.576409053997277e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25860,6041,1.14 [1.09-1.18],3.1128160030139016e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26661,185,1.07 [0.86-1.35],0.5278896536095462
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Endocarditis,25189,45,1.28 [0.81-2.02],0.2912825870310627
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27697,518,1.40 [1.22-1.60],9.07845713161084e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertension,26445,4920,1.13 [1.09-1.19],1.340573686806471e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26462,4937,1.14 [1.09-1.19],6.375375152064882e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27653,58,3.08 [2.53-3.76],7.647333189983355e-29
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21613,88,1.99 [1.46-2.73],1.588899300733884e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21587,62,1.91 [1.31-2.76],0.0006709364102906
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Hypotension,27710,699,1.15 [1.03-1.30],0.014947992084628
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27286,64,1.50 [1.03-2.20],0.036780842809661
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27247,1509,1.15 [1.06-1.24],0.000565951722761
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27589,309,1.18 [0.99-1.41],0.0572372274119978
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25339,195,1.36 [1.09-1.70],0.0059981597401002
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27553,598,1.17 [1.03-1.33],0.0142908566249665
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26222,484,1.14 [0.99-1.31],0.0703060293869881
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27756,120,1.20 [0.91-1.59],0.1990355889202077
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27798,204,1.12 [0.91-1.39],0.2856343020786772
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Oesophageal varices,26515,39,2.92 [2.31-3.68],1.5573878371395194e-19
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other aneurysm,27071,51,1.10 [0.72-1.69],0.6505977575566388
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arrhythmias,25384,240,1.36 [1.12-1.66],0.0021113069964497
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27085,65,1.21 [0.82-1.78],0.3309768676770133
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27164,144,1.51 [1.17-1.94],0.001496791225207
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25268,124,1.25 [0.95-1.65],0.1122078345065262
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other disorders of veins,26547,71,0.87 [0.61-1.23],0.4202380374395226
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26523,47,1.26 [0.81-1.98],0.3073782222748077
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27033,38,1.14 [0.69-1.88],0.6046278721676553
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26565,89,1.23 [0.89-1.71],0.2063324393399269
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25733,589,1.19 [1.05-1.36],0.0059586746306724
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27057,46,2.95 [2.28-3.83],3.663634199767759e-16
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27360,340,1.23 [1.04-1.45],0.0168538455234065
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27367,157,1.73 [1.37-2.19],4.69225533110869e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27230,235,1.21 [0.99-1.47],0.0664048758962203
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19177,250,1.23 [1.01-1.50],0.0409040243842704
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27203,209,1.46 [1.18-1.80],0.000476277952267
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26731,255,1.09 [0.90-1.32],0.3844510947966938
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27551,341,1.18 [1.00-1.39],0.0515012454916785
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27774,333,1.34 [1.13-1.58],0.0006327173837869
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25320,176,1.30 [1.03-1.64],0.0266735606606719
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27363,153,1.79 [1.42-2.27],1.2358050300360026e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27109,114,1.18 [0.88-1.57],0.2641912031112752
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27582,360,1.23 [1.04-1.44],0.0128129762314396
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27558,396,1.32 [1.13-1.54],0.000448026763565
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27264,55,1.66 [1.10-2.48],0.0149288989445297
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27075,56,0.84 [0.57-1.25],0.39768249692185
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27420,140,1.10 [0.85-1.42],0.4649875509101855
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27139,184,1.26 [1.00-1.58],0.046224728943191
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Varicose veins,26792,316,1.00 [0.85-1.19],0.9712788792716974
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27030,47,1.04 [0.67-1.62],0.8689859454135708
SLAMF1,Signaling lymphocytic activation molecule,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27646,536,1.14 [1.00-1.30],0.0481768178806684
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27657,381,1.25 [1.07-1.46],0.005729059678214
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24797,1439,1.10 [1.01-1.19],0.0227148743951035
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Any mental disorder,27050,3692,1.11 [1.06-1.17],2.947391164316554e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27593,452,1.16 [1.01-1.34],0.0400306875269305
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25028,1670,1.10 [1.02-1.19],0.0091892661402764
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23452,94,1.01 [0.74-1.38],0.9398722887584874
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Smoking dependency,27277,1537,1.21 [1.12-1.31],3.2851218399707165e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25143,1785,1.17 [1.09-1.27],2.428833932656852e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter V Mental and behavioural disorders,Vascular dementia,27699,22,1.34 [0.70-2.56],0.3717964702879246
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Alzheimer disease,27815,64,1.43 [0.98-2.08],0.0652225100303316
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Bell's palsy,26139,73,1.25 [0.87-1.79],0.223781862800053
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26544,478,0.88 [0.77-1.00],0.0582101763857792
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral cysts,27459,207,1.22 [0.99-1.51],0.0674326064155213
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27732,228,1.15 [0.94-1.40],0.1853873913950768
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27674,24,1.06 [0.57-1.96],0.8566276981855887
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27801,51,1.58 [1.05-2.37],0.0287339520484655
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27310,58,0.93 [0.63-1.37],0.6967388637427263
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Epilepsy,26255,258,1.10 [0.91-1.34],0.3078613440953434
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27327,1330,1.07 [0.99-1.17],0.0898456842530141
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27785,272,1.03 [0.86-1.23],0.7720439616073583
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27292,1658,1.10 [1.02-1.19],0.0122536797823817
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Generalized epilepsy,27445,52,1.17 [0.77-1.80],0.4648804527613303
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hemiplegia,27668,164,1.17 [0.92-1.49],0.1873519730602038
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Hydrocephalus,27299,47,1.50 [0.96-2.34],0.0717257706167081
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27791,63,1.06 [0.72-1.55],0.7694604544949795
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26147,81,0.92 [0.67-1.28],0.6382435241809241
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26152,86,1.14 [0.82-1.59],0.4323131918311961
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Memory loss,27665,75,1.32 [0.93-1.89],0.1204864378365729
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Migraine,26414,417,1.08 [0.93-1.26],0.2931941276843616
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27723,371,1.03 [0.88-1.20],0.7330523909749149
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Motor neuron disease,20259,96,1.31 [0.96-1.79],0.0888188255695221
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27618,148,1.06 [0.83-1.36],0.6328351487322739
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27198,1132,0.97 [0.89-1.06],0.5236541214912395
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Neurological diseases,26372,3079,1.06 [1.01-1.12],0.0280588209347159
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27724,74,1.38 [0.96-1.96],0.078395377746226
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26453,387,0.94 [0.80-1.09],0.3906247451078959
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27742,232,1.49 [1.22-1.81],8.340976527859855e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23208,308,1.18 [0.99-1.40],0.0678692671752551
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27311,59,1.27 [0.85-1.89],0.2403573406926157
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27369,117,1.33 [1.00-1.76],0.0499682290521232
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27604,91,1.27 [0.92-1.76],0.140633284843268
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26157,91,1.24 [0.90-1.71],0.1883010603606974
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other headache syndromes,26056,59,1.12 [0.75-1.66],0.5867169790908402
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other neurological diseases,27695,443,1.26 [1.09-1.46],0.0017500058857047
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Other sleep disorders,26575,578,1.07 [0.94-1.22],0.2772655305141916
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Parkinson's disease,27803,161,1.00 [0.79-1.27],0.9958679909825904
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27316,64,0.87 [0.60-1.24],0.4352673838889944
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Restless leg syndrome,27814,46,1.09 [0.70-1.70],0.7166752020349374
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Sleep apnoea,27565,502,1.03 [0.90-1.19],0.6279978244058901
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27545,35,1.37 [0.82-2.29],0.232323756759478
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27801,122,1.22 [0.92-1.61],0.165359703437561
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26098,32,1.67 [1.00-2.80],0.0503325741721939
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27815,65,1.42 [0.98-2.07],0.0666500044523769
SLAMF1,Signaling lymphocytic activation molecule,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27687,21,1.25 [0.64-2.43],0.5076817554478067
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27330,41,1.09 [0.67-1.75],0.7344906416319112
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27462,219,0.86 [0.70-1.04],0.1268060712575996
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27728,196,1.78 [1.45-2.18],4.43093128573306e-08
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27064,37,0.84 [0.53-1.35],0.4807994187348219
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27104,77,1.21 [0.85-1.71],0.2854218128679276
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27724,30,1.36 [0.78-2.36],0.2818238753887606
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27613,65,0.69 [0.49-0.98],0.0360183777632669
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1682,42,1.55 [1.02-2.34],0.0380224412239646
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1990,86,1.32 [0.97-1.81],0.0809340112129404
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27366,77,1.16 [0.82-1.65],0.3992688404869469
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27687,622,1.19 [1.06-1.35],0.0046693368703648
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27509,482,0.99 [0.86-1.13],0.8498868964863079
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27166,139,0.98 [0.76-1.26],0.8574789533339325
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27724,481,0.94 [0.82-1.07],0.3534215747029878
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27802,52,0.83 [0.55-1.23],0.3476114338698658
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27648,405,0.94 [0.81-1.09],0.4319856041392299
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27771,223,0.94 [0.77-1.14],0.5204720444102386
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27752,127,0.96 [0.74-1.26],0.7909364871676886
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27045,18,1.18 [0.58-2.44],0.6465547889643279
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27055,28,0.71 [0.42-1.18],0.1879862905140163
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27060,33,1.08 [0.64-1.84],0.7670224676737328
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27767,389,1.02 [0.87-1.19],0.8222025452553077
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27478,100,1.18 [0.87-1.60],0.2980236585694328
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27269,26,1.01 [0.56-1.83],0.9652450738067792
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27622,74,1.07 [0.75-1.53],0.691115155675726
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27698,150,0.86 [0.68-1.10],0.2293207605809696
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27404,161,0.96 [0.76-1.22],0.7482350318189788
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27698,73,0.88 [0.62-1.24],0.4597715166487489
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27637,259,1.05 [0.87-1.26],0.6322929015273191
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27408,119,1.05 [0.80-1.39],0.7296167311674271
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27103,1059,1.03 [0.94-1.13],0.4829702441420147
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27671,123,0.95 [0.73-1.25],0.7363528213567083
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27789,112,1.23 [0.92-1.64],0.1662746785326788
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27290,263,0.84 [0.71-1.01],0.0629515062948753
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27585,37,1.01 [0.62-1.66],0.9665322971993886
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27785,35,0.86 [0.53-1.41],0.5593400286405632
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27067,40,0.90 [0.57-1.44],0.6661862418782574
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27143,116,0.81 [0.62-1.05],0.1136111262094488
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27135,70,1.48 [1.03-2.13],0.0340584199589339
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27303,60,0.96 [0.66-1.42],0.8517265458473708
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27114,49,1.16 [0.75-1.79],0.5169921036016472
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27435,57,0.97 [0.65-1.44],0.867013826782826
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27470,92,0.94 [0.69-1.29],0.7076593755069404
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27117,90,0.90 [0.66-1.23],0.5097457166710615
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27190,125,0.82 [0.63-1.05],0.1180601706489253
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27100,35,1.75 [1.06-2.88],0.0292774187382514
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26877,833,1.03 [0.93-1.14],0.6164247140639116
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27077,50,0.93 [0.61-1.42],0.7451461899603007
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27602,313,1.08 [0.91-1.28],0.4020606840038826
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27328,39,1.11 [0.68-1.81],0.689082064265734
SLAMF1,Signaling lymphocytic activation molecule,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27416,127,1.67 [1.29-2.16],8.930465798128255e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27619,62,0.91 [0.63-1.32],0.6200200099071197
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27773,97,1.07 [0.79-1.46],0.6464609110771311
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27696,131,1.17 [0.90-1.53],0.242273868747458
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27612,55,1.76 [1.19-2.59],0.0046919843349665
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27608,51,0.89 [0.59-1.34],0.5824840506701725
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27727,535,1.10 [0.96-1.25],0.1755256828247665
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27530,338,1.13 [0.96-1.33],0.1484616908069314
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27287,95,0.87 [0.65-1.18],0.3797536352018408
SLAMF1,Signaling lymphocytic activation molecule,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27271,79,1.28 [0.91-1.80],0.1630905037142461
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute pharyngitis,27524,82,1.37 [0.98-1.92],0.0674918810190539
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27677,235,1.32 [1.08-1.61],0.0060320625439682
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27505,63,1.31 [0.89-1.93],0.1674217750622678
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza,26496,77,1.72 [1.23-2.41],0.0014409348584298
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26494,75,1.77 [1.27-2.48],0.0008507530752794
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20601,128,0.99 [0.76-1.30],0.9593992572509048
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Allergic rhinitis,27659,312,0.96 [0.81-1.14],0.6587513826548963
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22106,1775,1.12 [1.04-1.20],0.0021550808178554
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22219,1746,1.13 [1.05-1.21],0.0012247991219596
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27524,95,1.02 [0.75-1.39],0.8820219858778228
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26477,58,1.15 [0.77-1.72],0.5001965346914639
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Bronchiectasis,24751,184,1.35 [1.08-1.69],0.009533416255487
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24609,42,1.12 [0.70-1.79],0.6373417301766238
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26943,2376,1.15 [1.08-1.22],1.4323844228722362e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26325,70,1.08 [0.75-1.56],0.6685260580900889
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Chronic sinusitis,26426,171,0.92 [0.74-1.16],0.4860169468362825
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27706,729,1.31 [1.17-1.47],4.426979451099417e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Deviated nasal septum,26385,130,0.89 [0.69-1.15],0.3638017847441034
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25878,4291,1.13 [1.08-1.19],1.4307675099922658e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26635,380,1.03 [0.88-1.20],0.7342176604268039
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Early onset COPD,27485,508,1.30 [1.13-1.49],0.0001929170077799
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Emphysema,24753,186,1.51 [1.19-1.91],0.0005827446614692
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26556,114,2.00 [1.57-2.55],2.9758578362166933e-08
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27631,1212,1.30 [1.19-1.42],4.758930766251947e-09
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Interstitial lung disease,26581,139,1.85 [1.45-2.35],4.870123344681186e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Later onset COPD,26376,221,1.34 [1.08-1.65],0.0069130574184088
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27806,156,1.50 [1.18-1.91],0.0010371621158039
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Nasal polyp,26368,113,0.87 [0.66-1.15],0.3391368718811081
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27602,624,1.23 [1.09-1.40],0.0007673634455321
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of pleura,27639,1252,1.25 [1.15-1.37],4.086811552489666e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27147,892,0.98 [0.88-1.08],0.6398043241413377
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other pleural conditions,26421,34,1.13 [0.67-1.91],0.6530907812040061
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27760,202,1.67 [1.36-2.06],1.1324701211046347e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27732,855,1.24 [1.11-1.38],6.555261912387872e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural effusion,26981,594,1.31 [1.16-1.49],2.0822394791649023e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pleural plaque,26442,55,1.47 [0.97-2.22],0.069002475351741
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27421,1002,1.36 [1.23-1.50],7.24273398445569e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27786,136,1.39 [1.07-1.81],0.0141402823452374
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pneumothorax,26450,63,0.99 [0.68-1.44],0.9457522758108132
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pollen allergy,27778,265,0.93 [0.78-1.12],0.4600135260812246
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Pulmonary oedema,27597,39,1.54 [0.95-2.51],0.0819748009373493
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20510,37,1.95 [1.27-2.97],0.0020728799880217
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27585,607,1.28 [1.13-1.45],0.0001196978199978
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26567,312,0.96 [0.81-1.14],0.6698676906144561
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Viral pneumonia,26614,195,1.06 [0.85-1.32],0.601135708020746
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27546,168,1.16 [0.92-1.47],0.2090124224625098
SLAMF1,Signaling lymphocytic activation molecule,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16064,100,1.24 [0.91-1.71],0.1792367778901442
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21301,63,1.17 [0.80-1.74],0.4175077679904858
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute appendicitis,27610,159,0.82 [0.66-1.04],0.0966124320497489
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute gastritis,22237,74,1.49 [1.06-2.12],0.0234678643789675
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute pancreatitis,26220,168,1.12 [0.89-1.42],0.3363759905702336
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Acute peritonitis,27376,75,1.84 [1.34-2.53],0.0001556545160439
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27032,82,2.33 [1.84-2.96],2.345176655055594e-12
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Barrett oesophagus,22518,355,1.13 [0.96-1.32],0.1569223868246487
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26106,54,1.44 [0.95-2.18],0.0841083989055379
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27403,54,1.44 [0.95-2.18],0.0850169634339678
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholecystitis,26231,179,1.17 [0.93-1.47],0.1849863175910243
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Cholelithiasis,26957,905,1.11 [1.01-1.23],0.0352687021109453
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic gastritis,22418,255,1.28 [1.06-1.55],0.0102027298954585
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26096,44,1.78 [1.15-2.75],0.0096889999837871
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27672,77,2.72 [2.17-3.40],1.7583338188914156e-18
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Coeliac disease,26379,117,1.85 [1.44-2.38],1.6309629039084642e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Collagenous colitis,26240,59,0.78 [0.54-1.14],0.2009551477834436
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27627,207,1.12 [0.90-1.38],0.2997023381162532
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Constipation,27594,1178,1.17 [1.07-1.28],0.0004791187573148
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn disease,26277,96,1.57 [1.16-2.13],0.0036599088171894
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27465,67,1.86 [1.34-2.58],0.0002265241264178
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26275,94,1.74 [1.29-2.33],0.0002512833598943
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Dental caries,26969,270,1.22 [1.01-1.47],0.0393304512266688
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25730,1844,1.03 [0.96-1.11],0.4135276604558683
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of appendix,27654,203,0.79 [0.65-0.97],0.0226491475260853
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of liver,27698,748,1.52 [1.36-1.70],7.846021790317998e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26092,3929,1.12 [1.07-1.18],3.406689892640912e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27330,631,1.09 [0.97-1.23],0.1501744478672443
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27735,434,1.18 [1.02-1.36],0.029290387302988
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26836,137,1.09 [0.84-1.41],0.5342502345082711
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26667,69,1.00 [0.69-1.43],0.9862667250613772
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27536,1274,1.12 [1.03-1.22],0.0105386439313315
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diseases of tongue,26680,123,1.32 [1.00-1.75],0.0491209286915105
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27299,1247,1.14 [1.04-1.24],0.0034631491827599
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23693,2455,1.03 [0.97-1.09],0.3973900631146849
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Duodenal ulcer,22309,146,1.32 [1.02-1.70],0.0334635197162556
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27745,117,1.34 [1.01-1.78],0.0458975157565048
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27676,82,1.43 [1.03-1.99],0.0303114570791717
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27050,100,2.46 [2.00-3.03],3.014189525567269e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21417,179,1.13 [0.90-1.42],0.3056280997481103
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Functional dyspepsia,22683,520,1.10 [0.96-1.26],0.1600092454676998
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastric ulcer,22444,281,1.13 [0.94-1.35],0.2021590367162315
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24427,2264,1.12 [1.05-1.19],0.0006393919784581
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22570,407,1.20 [1.03-1.40],0.0185434537194421
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,22717,8142,1.07 [1.03-1.10],0.0002918381277606
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,GI-bleeding,27291,1029,1.08 [0.98-1.19],0.1174534668147052
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26761,62,1.45 [0.98-2.15],0.0610334188065771
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22176,1303,1.04 [0.96-1.13],0.338854078095036
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27007,57,2.60 [2.03-3.34],4.295016235448827e-14
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Hernia,26656,2770,1.05 [0.99-1.11],0.1240688590803928
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impacted teeth,27686,76,1.46 [1.04-2.04],0.0268568619143598
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Impaction of intestines,21271,33,1.06 [0.62-1.80],0.8334227110728739
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Inguinal hernia,24575,689,1.06 [0.94-1.19],0.3285342027452542
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",23966,80,0.84 [0.60-1.17],0.3074407135616828
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21313,75,1.84 [1.35-2.52],0.0001262702843141
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26399,137,1.75 [1.37-2.22],5.818825170073803e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21814,576,1.16 [1.02-1.31],0.0245804525352228
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27789,392,1.41 [1.21-1.65],9.78477910599242e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26891,710,1.13 [1.00-1.26],0.0445752344318828
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27076,895,1.17 [1.06-1.30],0.0025234998187241
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22318,155,1.11 [0.86-1.41],0.4217319643981067
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oesophagitis,22656,493,1.26 [1.09-1.44],0.0012316162867252
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27772,134,1.00 [0.77-1.29],0.990903659590402
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23933,47,1.29 [0.83-2.02],0.2578465832657055
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22553,1315,1.03 [0.95-1.12],0.4841128245140752
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26253,201,1.09 [0.88-1.35],0.445600648540955
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26210,158,1.15 [0.91-1.47],0.2459650880694194
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestine,22749,1511,1.03 [0.96-1.12],0.4111931384813033
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of intestines,26162,4924,1.03 [0.99-1.08],0.1223412483564547
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26673,198,1.02 [0.82-1.26],0.8723053788510389
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of liver,27558,608,1.52 [1.34-1.71],1.8056632916775625e-11
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22710,547,1.14 [1.00-1.29],0.0584483405953714
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26139,87,1.70 [1.23-2.34],0.0011559594128475
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27676,375,1.10 [0.94-1.29],0.2260390247395515
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22949,786,1.19 [1.07-1.33],0.0017864497439792
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27305,1043,1.07 [0.97-1.17],0.1735506206231225
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26890,191,1.05 [0.84-1.31],0.6573175743620572
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22462,1224,1.17 [1.08-1.28],0.0003230492422656
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23971,1808,1.16 [1.08-1.25],3.795074306986655e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27031,81,1.68 [1.22-2.32],0.0014715106336821
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26965,784,1.11 [1.00-1.24],0.0608879917746954
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21470,232,1.27 [1.04-1.56],0.0192340384557042
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27660,97,1.29 [0.95-1.75],0.1077427719442291
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21591,353,1.35 [1.14-1.58],0.0003593666154888
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26397,135,1.08 [0.83-1.41],0.5629535798179242
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27806,57,1.36 [0.91-2.03],0.1333344475710385
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26717,128,1.59 [1.23-2.05],0.0003969874195885
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Toxic colitis,26213,32,2.02 [1.26-3.22],0.0034296013614462
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22348,185,1.13 [0.91-1.42],0.2706152026708189
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ulcerative colitis,26330,149,1.67 [1.34-2.10],8.092862732470599e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26313,132,1.62 [1.27-2.07],9.970550928234548e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Umbilical hernia,24166,280,1.12 [0.93-1.35],0.2279673694519661
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21338,100,0.97 [0.72-1.31],0.832851545390169
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Ventral hernia,24112,226,1.36 [1.11-1.67],0.0030474276135978
SLAMF1,Signaling lymphocytic activation molecule,Chapter XI Diseases of the digestive system,Volvulus,21305,67,1.32 [0.90-1.92],0.1502638191293442
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27756,160,0.98 [0.77-1.24],0.8719032100546871
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27539,78,1.15 [0.82-1.63],0.4187158322317962
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26325,153,1.14 [0.89-1.45],0.3117196865048139
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27187,545,1.29 [1.13-1.47],0.0001812476829348
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26841,199,1.13 [0.91-1.40],0.2832057752279637
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26348,176,1.35 [1.07-1.70],0.0098442609283124
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27554,235,1.30 [1.06-1.59],0.0112721487680375
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27717,398,1.35 [1.16-1.57],0.0001370640177227
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27365,46,1.98 [1.39-2.82],0.0001583453665186
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26343,2593,1.16 [1.10-1.24],6.71259115591096e-07
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27357,443,0.98 [0.85-1.13],0.8027520525808571
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27230,316,1.08 [0.91-1.28],0.3734668333705023
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27421,779,1.23 [1.11-1.38],0.0001892779667812
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27803,47,0.61 [0.43-0.88],0.0081130861597515
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26228,56,0.91 [0.62-1.35],0.6390030858862343
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26956,42,1.17 [0.73-1.88],0.5037415077198085
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27547,228,1.30 [1.06-1.60],0.0109972048162347
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26464,292,1.03 [0.86-1.23],0.7269153615516177
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26209,37,1.19 [0.72-1.97],0.5050820022358813
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27732,70,1.23 [0.85-1.77],0.2719352123066244
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26776,134,1.14 [0.88-1.49],0.3194881866554553
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27620,159,1.10 [0.87-1.41],0.4230784741318429
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27352,33,1.47 [0.85-2.54],0.1654634323521639
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26225,53,0.88 [0.58-1.31],0.5190507925129149
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27290,1118,1.16 [1.06-1.28],0.0010359341735472
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26495,323,1.06 [0.89-1.25],0.5025381956153205
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26213,41,1.17 [0.72-1.88],0.5305074393837224
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27732,271,1.01 [0.84-1.22],0.8838369426498224
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27381,62,1.42 [0.97-2.09],0.0740488860223159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27684,223,1.13 [0.92-1.39],0.2425337430540835
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27780,184,1.04 [0.83-1.30],0.7440681776726608
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26299,127,1.25 [0.95-1.63],0.1105803463223718
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26364,192,1.13 [0.91-1.41],0.2665773197073351
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27770,174,1.03 [0.82-1.30],0.7693653340143558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26304,132,1.62 [1.26-2.10],0.0002011489466119
SLAMF1,Signaling lymphocytic activation molecule,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27783,121,1.50 [1.14-1.97],0.0037098165235322
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24414,134,0.99 [0.76-1.28],0.9125591885724658
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25969,4693,1.04 [0.99-1.08],0.1058677483537774
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24584,3308,1.04 [0.99-1.09],0.1604827376063073
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24374,94,0.93 [0.68-1.26],0.627291208770975
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24953,156,1.05 [0.82-1.34],0.6911192642145659
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24961,164,1.25 [0.99-1.59],0.063528554298489
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27584,118,1.10 [0.83-1.45],0.5261679850301446
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24844,47,1.72 [1.13-2.63],0.0115024468020696
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22027,751,1.07 [0.95-1.19],0.2638323338039361
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27755,122,1.01 [0.77-1.33],0.9159189320990814
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25089,292,1.05 [0.88-1.25],0.604237954540783
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24325,6296,1.04 [1.00-1.08],0.0367569181217574
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26443,112,1.21 [0.90-1.62],0.1984693439885465
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24399,119,1.48 [1.12-1.94],0.005731252421855
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24886,606,0.96 [0.85-1.08],0.51444842474675
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26920,2123,1.04 [0.98-1.12],0.1950747248910451
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24505,225,0.91 [0.74-1.11],0.3375557736294623
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24571,291,1.03 [0.87-1.24],0.7060601173760084
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24431,151,0.83 [0.66-1.05],0.1218994499730157
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27299,37,0.77 [0.48-1.21],0.2546687838227084
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22598,1322,0.99 [0.91-1.08],0.8758072332371651
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21676,400,1.17 [1.00-1.36],0.0522163513609159
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27762,392,1.19 [1.02-1.40],0.0268678251234072
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21347,71,0.64 [0.47-0.87],0.0042272488058742
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21622,346,1.00 [0.85-1.17],0.9869603644626984
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24614,334,1.04 [0.88-1.23],0.6208899124504507
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22050,774,1.01 [0.91-1.13],0.8508621657665666
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,24827,30,1.14 [0.65-1.99],0.6548562913934319
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25358,561,1.00 [0.88-1.13],0.9856809561469172
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25082,285,0.98 [0.82-1.17],0.7915683981339926
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,21998,722,1.01 [0.90-1.13],0.9063825435138916
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24367,87,1.40 [1.01-1.95],0.0426953099557697
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24341,61,1.28 [0.87-1.90],0.2125570950268787
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26389,58,1.68 [1.14-2.49],0.0094325669552256
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27480,1149,1.22 [1.11-1.33],1.6875328554899328e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26978,647,1.20 [1.06-1.35],0.0035020527502779
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27704,351,1.29 [1.10-1.52],0.0022076834695532
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23053,1777,1.10 [1.02-1.18],0.0094291194523133
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21357,81,1.35 [0.97-1.89],0.0758345613359471
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24361,81,1.17 [0.83-1.64],0.3762500554763649
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21302,26,0.69 [0.40-1.17],0.1686173140654021
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21387,111,0.84 [0.64-1.11],0.2218367307700233
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26567,236,1.25 [1.03-1.53],0.0256448007801461
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26571,240,1.09 [0.89-1.32],0.4146414400701045
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27774,84,1.34 [0.96-1.88],0.0816763221349807
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26379,1582,1.01 [0.94-1.09],0.7957172680246316
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24401,121,0.96 [0.73-1.26],0.7665134129449078
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21393,117,1.03 [0.78-1.36],0.8227220480335062
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25433,636,0.97 [0.86-1.09],0.6284802854247057
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23338,2062,1.05 [0.99-1.13],0.1231659129518727
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27322,60,0.95 [0.65-1.40],0.8065107781734957
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27789,75,1.17 [0.82-1.67],0.3770042697049106
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24366,86,1.11 [0.80-1.54],0.5271532455298062
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25398,1118,1.14 [1.04-1.25],0.0044232034696382
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24350,70,1.31 [0.91-1.89],0.1465802694157077
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22409,1133,1.04 [0.95-1.14],0.3408820499616467
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26433,102,1.02 [0.76-1.38],0.8808382788699289
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24346,66,1.36 [0.93-1.97],0.1108928987828247
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24916,119,1.01 [0.76-1.32],0.9665416617499256
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24686,406,1.27 [1.09-1.48],0.0017924308569003
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27468,206,1.35 [1.10-1.67],0.0050992985070828
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25267,470,0.98 [0.85-1.12],0.751447192893697
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27713,331,1.32 [1.12-1.57],0.0009926159369794
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27797,37,1.47 [0.90-2.41],0.1244077314422558
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24486,206,1.04 [0.84-1.28],0.7316672850074257
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22322,602,1.19 [1.05-1.35],0.0075735687817525
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24786,506,1.09 [0.95-1.25],0.2135594908674996
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24449,169,0.96 [0.76-1.21],0.7481601437169818
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21313,37,1.24 [0.75-2.05],0.4098164935244243
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23066,1790,1.10 [1.02-1.18],0.0105773507240991
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21732,456,1.09 [0.94-1.25],0.2581026279727862
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27349,87,1.41 [1.02-1.95],0.0391358446327152
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27740,50,1.20 [0.78-1.86],0.4027479510015914
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26196,27,0.88 [0.50-1.55],0.6621624119223166
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21352,76,1.20 [0.84-1.70],0.3132876513043308
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24886,89,1.28 [0.93-1.77],0.1285806956958652
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21631,355,1.29 [1.09-1.52],0.002366723385615
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24552,272,1.06 [0.88-1.27],0.5357025969848391
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25011,214,0.91 [0.75-1.11],0.3676679703143093
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24903,106,1.25 [0.93-1.69],0.1342596164339315
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23565,50,0.90 [0.60-1.35],0.6168400574934622
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27800,40,1.42 [0.88-2.28],0.1526077555625001
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24890,610,1.03 [0.91-1.17],0.6142659708577751
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27346,84,1.37 [0.98-1.91],0.0664872327141035
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26714,2434,1.05 [0.99-1.12],0.0905897646345813
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24389,109,1.36 [1.01-1.82],0.0418795446943733
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25157,360,1.00 [0.86-1.17],0.9738483918822564
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26407,191,1.07 [0.86-1.34],0.5286044458297748
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24946,149,0.87 [0.69-1.11],0.2583171503313095
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25872,1075,1.04 [0.95-1.14],0.3931554651703113
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25514,717,1.01 [0.91-1.13],0.8101871636752761
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24326,46,0.92 [0.60-1.42],0.7185361767702423
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27408,146,1.37 [1.07-1.76],0.0137011584605585
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24438,158,0.82 [0.65-1.03],0.0922417625551938
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24339,59,1.48 [0.99-2.21],0.0536878831409616
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21314,38,1.59 [1.00-2.53],0.0481046954029175
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27246,871,1.55 [1.40-1.72],4.064028651970304e-17
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11303,77,1.22 [0.86-1.73],0.2676459440760655
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15002,78,1.09 [0.77-1.53],0.6420538915314671
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27507,318,1.19 [1.00-1.41],0.0494824034728056
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27252,63,0.82 [0.57-1.18],0.2827420599830258
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27080,705,1.46 [1.30-1.65],2.2647189816553204e-10
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27620,32,2.48 [1.69-3.65],3.426136447958829e-06
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27637,194,0.99 [0.80-1.23],0.9277481564441538
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Cystitis,25580,157,1.08 [0.85-1.38],0.5195154900150492
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Dialysis,26436,61,2.07 [1.46-2.95],4.652558872616117e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12029,1148,0.94 [0.86-1.02],0.1506523031591975
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15130,206,1.06 [0.85-1.30],0.6165025951436425
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Endometriosis,11366,140,1.01 [0.78-1.29],0.9673940769848128
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11618,392,0.90 [0.77-1.04],0.1535377129885845
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11652,426,1.03 [0.89-1.19],0.6801396179787322
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23466,4315,1.10 [1.05-1.15],7.073882852913912e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27657,69,1.77 [1.25-2.50],0.0011635428686385
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydrocele,10970,89,1.02 [0.74-1.42],0.8881780145295343
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26288,227,1.13 [0.92-1.39],0.244518556748643
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11636,755,0.96 [0.86-1.07],0.4853594269921177
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,14995,240,1.08 [0.89-1.31],0.436329150358382
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10986,105,0.79 [0.59-1.04],0.0922323721069893
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Irregular menses,15001,129,0.98 [0.75-1.27],0.8592438431073144
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11526,300,0.90 [0.76-1.06],0.2131486223473185
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25490,67,1.48 [1.03-2.13],0.0326906855635096
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12644,1418,1.02 [0.94-1.10],0.6181297000729684
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,10930,49,1.17 [0.75-1.82],0.496020595712045
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11330,104,1.11 [0.83-1.50],0.4781695595679915
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27804,36,1.13 [0.68-1.88],0.6317490217650985
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27810,44,1.02 [0.65-1.60],0.9455133876318896
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26946,1523,1.13 [1.05-1.22],0.0019855240663405
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25897,474,0.93 [0.81-1.07],0.3173188446746661
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,14992,68,0.89 [0.63-1.27],0.5293500394772239
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27762,319,1.12 [0.94-1.33],0.199527042971927
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11037,156,0.93 [0.73-1.18],0.5626833861849645
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11001,120,0.96 [0.73-1.27],0.7767078843475832
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,10955,74,0.62 [0.45-0.84],0.0019601399097789
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27778,54,0.82 [0.56-1.21],0.3112571239253444
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26530,1107,1.21 [1.10-1.32],6.833750963607795e-05
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14878,123,0.93 [0.71-1.21],0.5932089547052095
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11311,85,1.06 [0.77-1.47],0.7171305529952121
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11457,231,1.08 [0.88-1.31],0.4675682975171397
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11285,59,1.30 [0.88-1.94],0.1904642207054407
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11331,105,1.09 [0.81-1.47],0.5560325265279884
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26321,260,1.13 [0.93-1.37],0.2204942795861411
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27554,111,1.03 [0.77-1.37],0.8538906051234614
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11409,183,1.01 [0.81-1.26],0.9285007576896308
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11308,82,0.83 [0.61-1.14],0.2534305279082596
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11661,435,1.08 [0.94-1.25],0.284769519475839
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11292,66,1.36 [0.94-1.98],0.1012877533272156
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11610,384,1.11 [0.95-1.30],0.1752206472187705
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27637,49,1.38 [0.89-2.14],0.1532238680495763
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10991,110,0.95 [0.71-1.27],0.7205861929206179
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27606,1545,1.38 [1.27-1.49],1.3801507878438797e-15
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26206,145,1.34 [1.03-1.73],0.0284453063498129
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26452,77,1.37 [0.96-1.96],0.0829043514013567
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27261,72,1.15 [0.80-1.65],0.4560293304596416
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25592,169,1.35 [1.07-1.71],0.0129404449830618
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27573,384,1.13 [0.97-1.32],0.1242720688262119
SLAMF1,Signaling lymphocytic activation molecule,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11332,106,1.06 [0.79-1.42],0.6934156115327809
